ClinVar Miner

Submissions for variant NM_001082486.2(ACD):c.1063C>T (p.Pro355Ser)

gnomAD frequency: 0.00001  dbSNP: rs757414908
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001066517 SCV001231530 uncertain significance Dyskeratosis congenita, autosomal dominant 6 2023-10-08 criteria provided, single submitter clinical testing This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 441 of the ACD protein (p.Pro441Ser). This variant is present in population databases (rs757414908, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with ACD-related conditions. ClinVar contains an entry for this variant (Variation ID: 860243). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ACD protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002379598 SCV002690433 uncertain significance Inborn genetic diseases 2021-07-07 criteria provided, single submitter clinical testing The p.P441S variant (also known as c.1321C>T), located in coding exon 10 of the ACD gene, results from a C to T substitution at nucleotide position 1321. The proline at codon 441 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
PreventionGenetics, part of Exact Sciences RCV003413886 SCV004118480 uncertain significance ACD-related disorder 2023-06-09 criteria provided, single submitter clinical testing The ACD c.1321C>T variant is predicted to result in the amino acid substitution p.Pro441Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.022% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-67692032-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.